Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia

Disease relapse is the most common cause of treatment failure after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndromes, yet treatment options for such patients remain extremely limited. Azacitidine is an important new therapy in high-risk myelodysplastic sy...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Haematologica
Autors principals: Craddock, Charles, Labopin, Myriam, Robin, Marie, Finke, Juergen, Chevallier, Patrice, Yakoub-Agha, Ibrahim, Bourhis, Jean Henri, Sengelov, Henrik, Blaise, Didier, Luft, Thomas, Hallek, Michael, Kröger, Nicolaus, Nagler, Arnon, Mohty, Mohamad
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2016
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5004468/
https://ncbi.nlm.nih.gov/pubmed/27081178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2015.140996
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars